Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Surgical and interventional devices / Consumables and single-use procedure-attached revenue (hospital and ASC)

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Consumables and single-use procedure-attached revenue (hospital and ASC)

Recurring, procedure-attached consumables used in surgical, endoscopic, interventional radiology and electrophysiology procedures: guidewires, catheters, stents, staplers, sutures, energy-device consumables, drapes and single-use access kits. Job is to enable each case reliably with acceptable cost per procedure and no stock-outs.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
85 /100
for B2B sellers
Evidence
not sized
1 source · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Hospitals and ambulatory surgery centres purchasing consumables through contracts, GPOs and distributors
Buying centre
Contracted purchasing and supply chain with clinical value-analysis sign-off; GPO and IDN category managers set terms
Buying triggers
  • Procedure volume growth driving consumable pull-through
  • Hospital and ASC cost-per-case reduction targets
  • Single-use conversion from reusable instruments
  • Supply-chain assurance and dual-sourcing requirements
  • New procedure indications and device launches
Pains
  • Price erosion under GPO and IDN contracts
  • Supply shortages and backorders on critical consumables
  • Waste and variability in per-case consumable use
  • Inventory carrying cost and expiry risk
Scores (1–5)
Pain intensity4
Purchasing power5
Reachability4
Growth4

How this was sized

Not sized yet

No source isolates consumables revenue for surgical and interventional devices. Proxy: consumables are typically the larger, faster-growing share of procedure-based device revenue, but the sources give no split. Bottom-up bound: if consumables are 50-60% of the USD 125bn-158bn hospital-plus-ASC surgical/interventional pool derived in the first niche, the consumables pool is roughly USD 63bn-95bn for 2026. Arithmetic: 125bn x 50% = 63bn; 158bn x 60% = 95bn. Low confidence: both the 50-60% consumables share and the underlying hospital/ASC pool are assumptions layered on the single 31% device-type share in [6].

Alongside it in Surgical and interventional devices

// Sell into Consumables and single-use procedure-attached revenue (hospital and ASC)

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.